Artelo Biosciences Statistics
Share Statistics
Artelo Biosciences has 3.28M
shares outstanding. The number of shares has increased by 1.65%
in one year.
| Shares Outstanding | 3.28M |
| Shares Change (YoY) | 1.65% |
| Shares Change (QoQ) | 1.65% |
| Owned by Institutions (%) | 3.26% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 274 |
| FTD / Avg. Volume | 0.07% |
Short Selling Information
The latest short interest is 874.82K, so 27.1% of the outstanding
shares have been sold short.
| Short Interest | 874.82K |
| Short % of Shares Out | 27.1% |
| Short % of Float | 27.33% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.83 and the forward
PE ratio is -1.94.
Artelo Biosciences's PEG ratio is
0.02.
| PE Ratio | -0.83 |
| Forward PE | -1.94 |
| PS Ratio | 0 |
| Forward PS | 0.1 |
| PB Ratio | 0.42 |
| P/FCF Ratio | -1.02 |
| PEG Ratio | 0.02 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Artelo Biosciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 18.36,
with a Debt / Equity ratio of 0.
| Current Ratio | 18.36 |
| Quick Ratio | 18.36 |
| Debt / Equity | 0 |
| Debt / EBITDA | -0.01 |
| Debt / FCF | -0.01 |
| Interest Coverage | -2057.4 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,645,666.67 |
| Employee Count | 6 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -209K |
| Effective Tax Rate | 2.07% |
Stock Price Statistics
The stock price has increased by -24.44% in the
last 52 weeks. The beta is 1.17, so Artelo Biosciences's
price volatility has been higher than the market average.
| Beta | 1.17 |
| 52-Week Price Change | -24.44% |
| 50-Day Moving Average | 0.98 |
| 200-Day Moving Average | 1.14 |
| Relative Strength Index (RSI) | 52.84 |
| Average Volume (20 Days) | 412,735 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -10.29M |
| Net Income | -9.87M |
| EBITDA | -10.29M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -3.49 |
Full Income StatementBalance Sheet
The company has 6.89M in cash and 63K in
debt, giving a net cash position of 6.83M.
| Cash & Cash Equivalents | 6.89M |
| Total Debt | 63K |
| Net Cash | 6.83M |
| Retained Earnings | -31.02M |
| Total Assets | 15.5M |
| Working Capital | 12.51M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -8.01M
and capital expenditures 0, giving a free cash flow of -8.01M.
| Operating Cash Flow | -8.01M |
| Capital Expenditures | n/a |
| Free Cash Flow | -8.01M |
| FCF Per Share | -2.83 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
